Now showing items 1-1 of 1

    • Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis. 

      Baker, D; Asardag, AN; Quinn, OA; Efimov, A; Kang, AS (2021-08-06)
      Multiple sclerosis is the major demyelinating autoimmune disease of the central nervous system. Relapsing MS can be treated by a number of approved monoclonal antibodies that currently target: CD20, CD25 (withdrawn), CD49d ...